alpha-glucosidase inhibitor

(redirected from Alpha glucosidase inhibitor)

α-glucosidase inhibitor

an oral agent that aids in the control of diabetes mellitus by delaying the absorption of glucose from the digestive system.

alpha-glucosidase inhibitor

any of a group of oral antihyperglycemic agents that act by competitive inhibition of alpha-glucosidase, delaying intestinal carbohydrate absorption and lessening postprandial increases in glucose levels.

alpha-glucosidase inhibitor

An oral drug that lowers blood sugars by preventing carbohydrate absorption from the gastrointestinal tract.
See also: inhibitor

α-glu·co·si·dase in·hib·i·tor

(glū-kō'si-dās in-hib'i-tŏr)
Oral agent that aids control of diabetes mellitus by delaying absorption of glucose from digestive system.
References in periodicals archive ?
In a further study, linagliptin monotherapy showed superiority in glucose lowering versus placebo and versus voglibose, the most commonly used alpha glucosidase inhibitor in Japan.
The alpha glucosidase inhibitor, acarbose (Precose), acts in the small intestine by delaying digestion of carbohydrates.
Therefore, sulfonylureas used in combination with alpha glucosidase inhibitors demonstrate synergistic effects in lowering fasting and postprandial glucose levels in NIDDM.
Alpha glucosidase inhibitors are suggested to be valuable aids in the treatment of diabetes.
Alpha glucosidase inhibitors inhibit an enzyme found in the brush boarder of the small intestine, which is responsible for the breakdown of complex carbohydrates.
The prescribed alpha glucosidase inhibitors were- voglibose 0.
However pioglitazone combination therapy with metformin and alpha glucosidase inhibitors (regimen C and D) revealed lower weight and BMI gain: 0.
Alpha glucosidase inhibitors and nonsulfonylurea secretogogues are probably somewhat less efficacious; combinations of medications seem to be additive.
Oral Drugs Market: (Metformin, Sulfonylureas, thaizolidinediones, dipeptidyl inhibitors, meglitinides, alpha glucosidase inhibitors, combination medications)
Keywords: Metformin intolerance, type 2 diabetes, sulfonylureas, alpha glucosidase inhibitors, pioglitazone, SGLT2 inhibitors, DPP4 inhibitors.
Alpha glucosidase inhibitors (AGIs) are a unique class of anti-diabetic drugs.